Urgent.News

What's breaking now, across thousands of outlets.

Business

AstraZeneca takes a £1.5bn stake in US cancer drug developer as it steps up investment in America

The British drugs company has ploughed £1.5bn into US pharma firm Summit Therapeutics as part of a cancer treatment research joint venture.

AstraZeneca takes a £1.5bn stake in US cancer drug developer as it steps up investment in America

We haven't written up this one. This Is Money has the full story — the link below goes straight to it.

Read the original at thisismoney.co.uk →

More in Business

More from Tuesday 29 September →